Skip to Content
Merck
All Photos(1)

Documents

SML3983

Sigma-Aldrich

BAY 2686013

new

≥98% (HPLC)

Synonym(s):

2-amino-N-(4-((3,5-bis(trifluoromethyl)benzyl)oxy)phenyl)acetamide hydrochloride

Sign Into View Organizational & Contract Pricing
All Photos(1)

About This Item

Empirical Formula (Hill Notation):
C17H14F6N2O2·HCl
Molecular Weight:
428.76
UNSPSC Code:
12352200

Quality Level

100

Assay

≥98% (HPLC)

form

powder

storage condition

desiccated

color

white to beige

solubility

DMSO: 2 mg/mL, clear

storage temp.

2-8°C

SMILES string

O=C(CN)NC(C=C1)=CC=C1OCC2=CC(C(F)(F)F)=CC(C(F)(F)F)=C2.Cl

Biochem/physiol Actions

Orally available, potent and selective allosteric antagonist of the human pituitary adenylate cyclase activating polypeptide receptor (hPAC1-R).



BAY 2686013 is an orally available, potent and selective allosteric antagonist of the human pituitary adenylate cyclase activating polypeptide receptor (hPAC1-R).

Caution

Hygroscopic

Storage Class Code

11 - Combustible Solids

WGK

WGK 3

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable

Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Gernot Langer et al.
Molecular pharmacology, 104(3), 105-114 (2023-06-23)
The human pituitary adenylate cyclase-activating polypeptide receptor (hPAC1-R), a class B G-protein-coupled receptor (GPCR) identified almost 30 years ago, represents an important pharmacological target in the areas of neuroscience, oncology, and immunology. Despite interest in this target, only a very

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service